Quantification of adaptive immune responses against protein binding interfaces in the streptococcal M1 protein.

SWATH-MS Streptococcus pyogenes host-pathogen interactions immune response mouse model

Journal

Molecular & cellular proteomics : MCP
ISSN: 1535-9484
Titre abrégé: Mol Cell Proteomics
Pays: United States
ID NLM: 101125647

Informations de publication

Date de publication:
23 Mar 2024
Historique:
received: 03 04 2023
revised: 28 02 2024
accepted: 22 03 2024
medline: 26 3 2024
pubmed: 26 3 2024
entrez: 25 3 2024
Statut: aheadofprint

Résumé

Bacterial or viral antigens can contain subdominant protein regions that elicit weak antibody responses upon vaccination or infection although there is accumulating evidence that antibody responses against subdominant regions can enhance the protective immune response. One proposed mechanism for subdominant protein regions is binding of host proteins that prevent antibody production against epitopes hidden within the protein binding interfaces. Here, we used affinity-purification combined with quantitative mass spectrometry (AP-MS) to examine the level of competition between antigen-specific antibodies and host-pathogen protein interaction networks using the M1 protein from Streptococcus pyogenes as a model system. As most humans have circulating antibodies against the M1 protein, we first used AP-MS to show that the M1 protein interspecies protein network formed with human plasma proteins is largely conserved in naïve mice. Immunizing mice with the M1 protein generated a time-dependent increase of anti-M1 antibodies. AP-MS analysis comparing the composition of the M1-plasma protein network from naïve and immunized mice showed a significant enrichment of 292 IgG peptides associated with 56 IgG chains in the immune mice. Despite the significant increase of bound IgGs, the levels of interacting plasma proteins were not significantly reduced in the immune mice. The results indicate that the antigen-specific polyclonal IgG against the M1 protein primarily targets epitopes outside the other plasma protein binding interfaces. In conclusion, this study demonstrates that AP-MS is a promising strategy to determine the relationship between antigen-specific antibodies and host-pathogen interaction networks that could be used to define subdominant protein regions of relevance for vaccine development.

Identifiants

pubmed: 38527648
pii: S1535-9476(24)00043-4
doi: 10.1016/j.mcpro.2024.100753
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100753

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest statement The authors declare no conflict of interest.

Auteurs

E Torres-Sangiao (E)

Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Division of Infection Medicine. BMC D13, SE-22184, Lund, Sweden; Health Research Institute of Santiago de Compostela (IDIS), Escherichia coli group. 15706 Santiago de Compostela, Spain; University Hospital Complex of Santiago de Compostela, Clinical Microbiology Lab. 15706 Santiago de Compostela, Spain. Electronic address: eva.torres.sangiao@gmail.com.

L Happonen (L)

Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Division of Infection Medicine. BMC D13, SE-22184, Lund, Sweden.

M Heusel (M)

Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Division of Infection Medicine. BMC D13, SE-22184, Lund, Sweden; Evosep ApS, Buchwaldsgade 35, Odense, Denmark.

F Palm (F)

Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Division of Infection Medicine. BMC D13, SE-22184, Lund, Sweden.

C Gueto-Tettay (C)

Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Division of Infection Medicine. BMC D13, SE-22184, Lund, Sweden.

L Malmström (L)

Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Division of Infection Medicine. BMC D13, SE-22184, Lund, Sweden.

O Shannon (O)

Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Division of Infection Medicine. BMC D13, SE-22184, Lund, Sweden; Section for Oral Biology and Pathology, Faculty of Odontology, Malmö University, 20506 Malmö, Sweden.

J Malmström (J)

Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Division of Infection Medicine. BMC D13, SE-22184, Lund, Sweden. Electronic address: johan.malmstrom@med.lu.se.

Classifications MeSH